Elevating Dermatology Prior Authorization Automation

The Unique Prior Authorization Landscape in Dermatology

Prior authorization in dermatology is concentrated around high-cost specialty drugs and specific procedures. This includes biologics for conditions like psoriasis, psoriatic arthritis, atopic dermatitis, and hidradenitis suppurativa, as well as procedures such as Mohs micrographic surgery. The necessity for periodic re-authorization for chronic treatments and the distinction between medical and pharmacy benefits further complicate workflows for dermatology teams.

Common Dermatology PA Triggers and Documentation Requirements

• **Biologics for psoriasis/PsA:** TNF inhibitors (e.g., adalimumab, etanercept), IL-17 inhibitors (e.g., secukinumab, ixekizumab), IL-23 inhibitors (e.g., guselkumab, risankizumab), and oral targeted therapies. Documentation requires diagnosis criteria (PASI/BSA), prior topical/phototherapy/conventional systemic therapy trials, and pre-biologic screenings (TB, hepatitis) per AAD Clinical Guidelines.
• **Biologics for atopic dermatitis:** Such as dupilumab, tralokinumab, and oral JAK inhibitors. Requires diagnosis criteria, EASI/SCORAD severity documentation, and topical therapy trials.
• **Hidradenitis suppurativa biologics:** Including adalimumab and secukinumab, often requiring specific disease severity and prior therapy documentation.
• **Mohs micrographic surgery:** High volume for non-melanoma skin cancers in cosmetically sensitive areas. Payer policies often require documentation of site, tumor type, and conformance to AAD Appropriate Use Criteria.
• **Advanced skin cancer treatments:** Immunotherapy (e.g., pembrolizumab, nivolumab) and targeted therapy for melanoma, guided by NCCN guidelines.
• **Home Phototherapy:** Narrowband UVB, PUVA, or excimer laser when prescribed for self-administration, often requiring documentation of prior topical therapy trials.

Addressing Denial Vectors and Workflow Constraints

Dermatology practices frequently encounter denials due to unmet step therapy requirements for biologics, documentation gaps for disease severity (e.g., missing PASI or EASI scores), or Mohs AUC mismatches. Klivira's platform is designed to proactively address these issues by validating criteria at the point of order, ensuring documentation completeness, and routing requests through the most efficient payer channels, including Da Vinci PAS API and X12 278.

Klivira's Precision Approach to Dermatology Prior Authorization Automation

Klivira's platform integrates directly with your EMR via SMART on FHIR and CDS Hooks to detect PA requirements at order entry, preventing missed authorizations. Our payer policy engine incorporates AAD-guideline-aware step-therapy logic for biologics and AUC validation for Mohs surgery, significantly reducing manual review and common denial reasons. We manage periodic re-authorizations and accurately route requests based on medical versus pharmacy benefits.

Klivira's Specific Capabilities for Dermatology Workflows

• **AAD-Guideline-Aware Logic:** Automates step-therapy validation for psoriasis and atopic dermatitis biologics, ensuring adherence to clinical best practices and payer requirements.
• **Mohs AUC Validation:** Verifies Mohs surgery requests against Appropriate Use Criteria at the point of order, reducing denials related to site or tumor type mismatches.
• **Automated Re-authorization:** Manages periodic re-authorization cycles for chronic biologic treatments, proactively initiating and tracking renewals.
• **Medical vs. Pharmacy Benefit Routing:** Intelligently routes prior authorization requests based on whether the drug is administered in-clinic (medical benefit) or self-injected at home (pharmacy benefit).
• **Comprehensive Documentation Assembly:** Leverages FHIR resources to automatically pull clinical notes, lab results, and prior therapy history from the EMR, assembling payer-specific documentation packets.
• **Real-time Status Tracking:** Provides transparent, real-time status updates on all submitted prior authorizations, reducing follow-up calls and improving operational visibility.

Seamless EMR and Payer Integration for Dermatology

Klivira integrates with leading EMR systems including Epic, Cerner, and athenahealth via SMART on FHIR and CDS Hooks, enabling automated PA detection at the point of order. We connect to payers through Da Vinci PAS, X12 278, and provider portal APIs, ensuring requests are submitted through the most efficient electronic channels. This end-to-end connectivity minimizes manual intervention, reduces administrative burden, and accelerates decision times, aligning with CMS-0057-F interoperability mandates.